In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment-Reference-Cited by-同舟云学术

In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment

Published:2015-06 Issue: Volume:1609 Page:1-11
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Yang Li,Islam Mohammad R.,Karamyan Vardan T.,Abbruscato Thomas J.

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference52 articles.

1. Brain and spinal cord distribution of biphalin, correlation with opioid receptor density and a mechanism of CNS entry;Abbruscato;J. Neurochem.,1997

2. A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia;Adams;Stroke,1986

3. Hibernation-like state induced by an opioid peptide protects against experimental stroke;Borlongan;BMC Biol.,2009

4. Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice;Boutin;Stroke,1999

5. Apoptotic mechanisms after cerebral ischemia;Broughton;Stroke,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Permeability of Metformin across an In Vitro Blood–Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs);Pharmaceutics;2023-04-28

2. Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats;Experimental Neurology;2022-11

3. Short-term exposure to JUUL electronic cigarettes can worsen ischemic stroke outcome;Fluids and Barriers of the CNS;2022-09-09

4. Transport Mechanisms at the Blood–Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs;Pharmaceutics;2022-07-20

5. In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals;Pharmaceutical Research;2022-03-03